Dx dialogues: the importance of comprehensive testing in oncology
Dx dialogues: why staying current with technology is critical in oncology
Dx dialogues: using NGS data to develop MRD assessment techniques for R/R AML
Dx dialogues: using molecular profiling to identify mutations in R/R AML
Dx dialogues: changes in treatment sequencing for metastatic breast cancer
Dx dialogues: advancements in treating indolent systemic mastocytosis
Dx dialogues: a potential paradigm shift in the treatment of metastatic breast cancer
Dx dialogues: other potential treatments for indolent systemic mastocytosis
Dx dialogues: helping physicians identify patients for combination therapies with CAR-T
Dx dialogues: diagnosing indolent systemic mastocytosis
What to ask your cancer care team when starting any new treatment for a desmoid tumor, including medications and surgery.
An overview of therapies used to treat desmoid tumors, including active surveillance, targeted therapies, and surgery.
Desmoid tumors are noncancerous and do not metastasize, but they can invade nearby tissues and structures.
Although it’s not the most common cancer, it is among the most deadly. Here’s why—and why there’s hope for future treatments.
Why monitoring and managing protein levels in the urine is a focus of treatment for this rare kidney disease.